Key Financial Data:
January 1 to December 31, 2016 / Outlook for 2017

March 3, 2017
Mari Sugata
Regional communications

A good performance in 2016
Acquisitions strengthen growth segments

TEL +81 (0)3 5323-7319
FAX +81 (0)3 5323-7398
info-jp@evonik.com

 Forecast fully achieved: adjusted EBITDA is

at the upper end of the range at €2.165 billion
 Proposed dividend: constant at an attractive levelof €1.15 per share Outlook for 2017: higher revenues and earnings, adjusted

EBITDA between €2.2 billion and €2.4 billion

Essen. Evonik Industries AG fully achieved its earnings forecast in
2016. With adjusted EBITDA of €2.165 billion, earnings were at
the upper end of the range of €2.0 billion to €2.2 billion. Whilevolumes grew by a 3 solid percent, sales declined 6 percent to€12.7 billion as a result of lower prices.
“At 17 percent, our adjusted EBITDA margin remains good,” said
Klaus Engel, Chairman of the Executive Board. “The successfulacquisition of the Air Products specialty additives business andthe planned acquisition of Huber's silica business provide
additional growth impetus and open up further perspectives forour attractive portfolio.”
At the Annual Shareholders’ Meeting on May 23, the Executive
Board and Supervisory Board will be proposing a dividend of €1.15
per share. Based on the closing share price at year-end 2016, thatgives a dividend yield of 4.1 percent, positioning Evonik among
the top chemical companies. “The high free cash flow of €810
million enables us to make this level of payout without impairing
our ambitious growth targets,” said Engel.
Following an exceptionally strong performance in the previousyear, the earnings situation normalized in 2016. Evonik was only

Evonik Japan Co., Ltd.
Shinjuku Monolith 12F
2-3-1, Nishi-Shinjuku, Shinjukuku

Page 1 of 4

Tokyo 163-0938
www.evonik.jp

partially able to compensate for the low global economic
momentum, the low oil price, and the normalization of prices foranimal nutrition products. Adjusted EBITDA was therefore
12 percent below the previous year's outstanding level. Adjusted
net income also dropped year-on-year to €930 million.
Evonik's financial position is still very sound. “The structure of ourbalance sheet remains healthy, even after acquiring the Air
Products specialty additives business,” said CFO Ute Wolf. This isalso evidenced by solid investment-grade ratings. “Capitalefficiency and cash flow will continue to play a central role in themanagement of the company,” said Wolf.
The return on capital employed (ROCE) was 14 percent in 2016
and thus once again well above the cost of capital.
Evonik expects the Nutrition & Care and Resource Efficiency
growth segments to make a positive earnings contribution in2017 as a result of the successful integration of the Air Products
specialty additives business. In addition, the company’s strong
market positions, balanced portfolio and concentration on highgrowth businesses will continue to drive its performance.
Despite the increasing uncertainty inherent in the geopoliticalsituation and high market volatility, Evonik aims to grow revenues
and operating earnings in 2017 and expects adjusted EBITDA tobe between €2.2 billion and €2.4 billion.

Page 2 of 4

Evonik Group: Excerpt from the income statement(in € million)

Q42016Q42015

Changein %2016

2015

Changein %Sales

3,205

3,198

0

12,732

13,507-6

Adjusted EBITDA

437

501

-13

2,165

2,465

-12

Adjusted EBIT

258

308

-16

1,448

1,752

-17

Adjustments

-76

-82

-150

-88

-174

-223

1,124

1,441

-362

-422

762

1,019

96

-17

858
14
844
930

1,002
11
991
1,128

Financial result
Income before income taxes, continuing
operations

8-22

190

204

Income taxes

-66

-70

Income after taxes, continuing operations

124

134

Income after taxes, discontinued operations

95-2

Income after taxes
thereof attributable to non-controlling interests= Net income
Adjusted net income

219
3216
182

132
3129205

Q42016€
millionSales
Q42015€
millionChangeNutrition & Care

1,093

1,208-10209

319

-34

Resource Efficiency

1,081

1,001

8189

182

4

Performance Materials

846

789

798

62

58

Services

180

203

-11

32

40

-20

5-3--91

-102

-

3,205

3,198

0437

2016
€
million
4,316
4,473
3,245
683
15
12,732

Sales
2015
€
million
4,924
4,279
3,435
828
41
13,507-7-76667-11-22-25-14-15-18

Segment performance

Other operations
Group

Nutrition & Care
Resource Efficiency
Performance Materials
Services
Other operations
Group
Prior-year figures restated

Page 3 of 4

in %Changein %-12
5-6-18-6

Adjusted EBITDA
Q4Q42016
2015
Change€€in %millionmillion501-13Adjusted EBITDA
2016
2015
Change€€in %millionmillion
1,006
1,435-30
977
896
9371
309
20151
159-5-340-334
2,165
2,465-12

Employees by segment
Nutrition & Care
Resource Efficiency
Performance Materials
Services
Other operations
EvonikDec. 31, 2016
7,594
8,928
4,393
12,892544
34,351

Prior-year figures restatedCompany information
Evonik, the creative industrial group from Germany, is one of the world leadersin specialty chemicals. Profitable growth and a sustained increase in the value ofthe company form the heart of Evonik’s corporate strategy. Its activities focus on
the key megatrends health, nutrition, resource efficiency and globalization.
Evonik benefits specifically from its innovative prowess and integrated
technology platforms.
Evonik is active in over 100 countries around the world with more than 35,000
employees. In fiscal 2016 the enterprise generated sales of around €12,7 billion
and an operating profit (adjusted EBITDA) of about €2.165 billion.
Disclaimer
In so far as forecasts or expectations are expressed in this press release or whereour statements concern the future, these forecasts, expectations or statements
may involve known or unknown risks and uncertainties. Actual results ordevelopments may vary, depending on changes in the operating environment.
Neither Evonik Industries AG nor its group companies assume an obligation to
update the forecasts, expectations or statements contained in this release.

Page 4 of 4Dec. 31, 2015
7,165
8,662
4,380
12,668701
33,576